Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
153 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
Rank Status Study
21 Recruiting A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.
Condition: Hypertension, Hyperlipidemia
Intervention: Drug: Fimasartan, Atorvastatin
22 Recruiting Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia
Condition: Oxidative Stress
Interventions: Dietary Supplement: XXS;   Dietary Supplement: non-XXS
23 Recruiting Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflamation Study in Patients With Elevated Lipoprotein(a) (Lp(a)).
Condition: Subjects With Hyperlipidemia, Dyslipidemia
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
24 Not yet recruiting Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
Condition: Hypertension and Hyperlipidemia
Interventions: Drug: YHP1701;   Drug: YHR1703;   Drug: YHR1704
25 Recruiting Chart Review of Repatha® in Subjects With Hyperlipidaemia
Condition: Hypercholesterolaemia
Intervention:
26 Not yet recruiting Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin
Conditions: Hypertension;   Hyperlipidemia
Interventions: Drug: Temisartan/Amlodipine+Rosuvastatin;   Drug: YHP1604
27 Recruiting The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers
Conditions: Diabetes;   Hyperlipidemia
Interventions: Drug: Metformin + Rosuvastatin;   Drug: JLP-1310
28 Recruiting Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers
Conditions: Diabetes;   Hyperlipidemia
Interventions: Drug: JLP-1310, Fasted followed by fed;   Drug: JLP-1310, Fed followed by fasted
29 Recruiting The SCCS Polypill Pilot Trial
Conditions: Hypertension;   Hyperlipidemia
Intervention: Drug: Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)
30 Recruiting Pharmacokinetic Drug-drug Interaction of CKD-330 and D086
Conditions: Hypertension;   Hyperlipidemias
Interventions: Drug: CKD-330;   Drug: D086;   Drug: CKD-330 + D086
31 Recruiting DP-R212 Pharmacokinetic Study
Conditions: Hypertension;   Hyperlipidemias
Interventions: Drug: Amlodipine;   Drug: Rosuvastatin
32 Recruiting Effect of Palm Olein Intake on Lipid Profile and Appetite Regulation
Condition: Lipidaemia
Interventions: Dietary Supplement: Palm olein;   Dietary Supplement: Interesterified palm olein;   Dietary Supplement: Soybean oil
33 Not yet recruiting Effect of Rosuvastatin Therapy on HDL2 Level
Conditions: Hyperlipemia;   Coronary Heart Disease
Interventions: Drug: Rosuvastatin 10mg/d group;   Drug: Rosuvastatin 20mg/d group
34 Recruiting Dried Blood Spot- Statin Pilot Study
Conditions: Hyperlipidemias;   Cardiovascular Diseases
Intervention: Other: Dried blood spot testing and phlebotomy
35 Not yet recruiting Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects
Condition: Menopause
Interventions: Drug: Estrogens;   Other: Placebo
36 Recruiting Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Disease
Interventions: Drug: bempedoic acid;   Drug: placebo
37 Recruiting Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Dapagliflozin
38 Recruiting Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Irbesartan/atorvastatin fixed dose combination;   Drug: Irbesartan SR47436;   Drug: Atorvastatin
39 Recruiting Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
Conditions: Atherosclerosis;   Hyperlipidemia
Intervention: Drug: Alirocumab
40 Not yet recruiting Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control
Conditions: Cardiovascular Diseases;   Hyperlipidemias
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.